Modulating the Glucose-dependent Insulinotropic Polypeptide (GIP) System in Patients With Acromegaly Due to a Pituitary Tumor
Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• Patients under clinical investigation of acromegaly disease with normal kidney function, liver function and hemoglobin levels.
Locations
Other Locations
Denmark
Department of Biomedical Sciences
Copenhagen
Time Frame
Start Date: 2019-08-13
Completion Date: 2023-11-28
Participants
Target number of participants: 25
Treatments
Other: GIP-A
Infusion of GIP-A alone as a study tool.
Placebo_comparator: Placebo
Saline
Related Therapeutic Areas
Sponsors
Collaborators: Odense University Hospital, Herlev and Gentofte Hospital, Aalborg University Hospital, Aarhus University Hospital, Rigshospitalet, Denmark
Leads: University of Copenhagen